{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:04:18Z","timestamp":1740157458974,"version":"3.37.3"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nonalcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disease in the world. New non-invasive diagnostic tools are needed to promptly treat this disease and avoid its complications. This study aimed to find key metabolites and related variables that could be used to predict and diagnose NAFLD. Ninety-eight subjects with NAFLD and 45 controls from the Fatty Liver in Obesity (FLiO) Study (NCT03183193) were analyzed. NAFLD was diagnosed and graded by ultrasound and classified into two groups: 0 (controls) and \u2265 1 (NAFLD). Hepatic status was additionally assessed through magnetic resonance imaging (MRI), elastography, and determination of transaminases. Anthropometry, body composition (DXA), biochemical parameters, and lifestyle factors were evaluated as well. Non-targeted metabolomics of serum was performed with high-performance liquid chromatography coupled to time-of-flight mass spectrometry (HPLC-TOF-MS). Isoliquiritigenin (ISO) had the strongest association with NAFLD out of the determinant metabolites. Individuals with higher concentrations of ISO had healthier metabolic and hepatic status and were less likely to have NAFLD (OR 0.13). Receiver operating characteristic (ROC) curves demonstrated the predictive power of ISO in panel combination with other NAFLD and IR-related variables, such as visceral adipose tissue (VAT) (AUROC 0.972), adiponectin (AUROC 0.917), plasmatic glucose (AUROC 0.817), and CK18-M30 (AUROC 0.810). Individuals with lower levels of ISO have from 71 to 82% more risk of presenting NAFLD compared to individuals with higher levels. Metabolites such as ISO, in combination with visceral adipose tissue, IR, and related markers, constitute a potential non-invasive tool to predict and diagnose NAFLD.<\/jats:p>","DOI":"10.1007\/s13105-023-00998-6","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T03:02:11Z","timestamp":1700794931000},"page":"639-653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease"],"prefix":"10.1007","volume":"80","author":[{"given":"Paola","family":"Mogna-Pel\u00e1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Romo-Hualde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 I.","family":"Riezu-Boj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fermin I.","family":"Milagro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mu\u00f1oz-Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 I.","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Elorz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Benito-Boillos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Ignacio","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep A.","family":"Tur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"Abete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3926-0892","authenticated-orcid":false,"given":"M. Angeles","family":"Zulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"998_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/S13105-021-00852-7","volume":"78","author":"A Abdolahi","year":"2022","unstructured":"Abdolahi A, Vahabzadeh Z, Izadpanah E, Moloudi MR (2022) Vaspin attenuates steatosis-induced fibrosis via GRP78 receptor by targeting AMPK signaling pathway. J Physiol Biochem 78:185\u2013197. https:\/\/doi.org\/10.1007\/S13105-021-00852-7","journal-title":"J Physiol Biochem"},{"key":"998_CR2","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1039\/C7FO00996H","volume":"8","author":"P Aranaz","year":"2017","unstructured":"Aranaz P, Romo-Hualde A, Zabala M, Navarro-Herrera D, Ruiz De Galarreta M, Gil AG, Martinez JA, Milagro FI, Gonz\u00e1lez-Navarro CJ (2017) Freeze-dried strawberry and blueberry attenuates diet-induced obesity and insulin resistance in rats by inhibiting adipogenesis and lipogenesis. Food Funct 8:3999\u20134013. https:\/\/doi.org\/10.1039\/C7FO00996H","journal-title":"Food Funct"},{"key":"998_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C (2006) The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6:1\u20137. https:\/\/doi.org\/10.1186\/1471-230X-6-33","journal-title":"BMC Gastroenterol"},{"key":"998_CR4","doi-asserted-by":"publisher","unstructured":"Botta M, Audano M, Sahebkar A, Sirtori CR, Mitro N, Ruscica M (2018) PPAR agonists and metabolic syndrome: an established role? Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/IJMS19041197","DOI":"10.3390\/IJMS19041197"},{"key":"998_CR5","doi-asserted-by":"publisher","unstructured":"Boutari C, Mantzoros CS (2020) Adiponectin and leptin in the diagnosis and therapy of NAFLD. Metabolism 103. https:\/\/doi.org\/10.1016\/J.METABOL.2019.154028","DOI":"10.1016\/J.METABOL.2019.154028"},{"key":"998_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.7150\/ijms.28044","volume":"16","author":"I Cantero","year":"2019","unstructured":"Cantero I, Elorz M, Abete I, Marin BA, Herrero JI, Monreal JI, Benito A, Quiroga J, Mart\u00ednez A, Huarte MP, Uriz-Otano JI, Tur JA, Kearney J, Alfredo Martinez J, Angeles Zulet M (2019) Ultrasound\/elastography techniques, lipidomic and blood markers compared to magnetic resonance imaging in non-alcoholic fatty liver disease adults. Int J Med Sci 16:75\u201383. https:\/\/doi.org\/10.7150\/ijms.28044","journal-title":"Int J Med Sci"},{"key":"998_CR7","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R (2019) Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease HHS public access. Gastroenterology 156:1264\u20131281. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.036","journal-title":"Gastroenterology"},{"key":"998_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"998_CR9","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/S41591-022-02014-8","volume":"28","author":"L Chen","year":"2022","unstructured":"Chen L, Zhernakova DV, Kurilshikov A, Andreu-S\u00e1nchez S, Wang D, Augustijn HE, Vich Vila A, Weersma RK, Medema MH, Netea MG, Kuipers F, Wijmenga C, Zhernakova A, Fu J (2022) Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome. Nat Med 28:2333\u20132343. https:\/\/doi.org\/10.1038\/S41591-022-02014-8","journal-title":"Nat Med"},{"key":"998_CR10","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1007\/s00394-021-02508-0","volume":"60","author":"A Cuevas-Sierra","year":"2021","unstructured":"Cuevas-Sierra A, Romo-Hualde A, Aranaz P, Goni L, Cuervo M, Mart\u00ednez JA, Milagro FI, Riezu-Boj JI (2021) Diet- and sex-related changes of gut microbiota composition and functional profiles after 4 months of weight loss intervention. Eur J Nutr 60:3279\u20133301. https:\/\/doi.org\/10.1007\/s00394-021-02508-0","journal-title":"Eur J Nutr"},{"key":"998_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1017\/S0007114513002778","volume":"111","author":"R De La Iglesia","year":"2014","unstructured":"De La Iglesia R, Lopez-Legarrea P, Abete I, Bondia-Pons I, Navas-Carretero S et al (2014) A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American heart association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project. Bri J Nutrition 111:643\u2013652. https:\/\/doi.org\/10.1017\/S0007114513002778","journal-title":"Bri J Nutrition"},{"key":"998_CR12","doi-asserted-by":"publisher","unstructured":"Deprince A, Haas JT, Staels B (2020) Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metab 42. https:\/\/doi.org\/10.1016\/J.MOLMET.2020.101092","DOI":"10.1016\/J.MOLMET.2020.101092"},{"key":"998_CR13","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3748\/WJG.V24.I27.2974","volume":"24","author":"YL Fang","year":"2018","unstructured":"Fang YL, Chen H, Wang CL, Liang L (2018) Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d. World J Gastroenterol 24:2974\u20132983. https:\/\/doi.org\/10.3748\/WJG.V24.I27.2974","journal-title":"World J Gastroenterol"},{"key":"998_CR14","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1080\/09637486.2018.1455813","volume":"69","author":"E Fattore","year":"2018","unstructured":"Fattore E, Massa E (2018) Dietary fats and cardiovascular health: a summary of the scientific evidence and current debate. Int J Food Sci Nutr 69:916\u2013927. https:\/\/doi.org\/10.1080\/09637486.2018.1455813","journal-title":"Int J Food Sci Nutr"},{"key":"998_CR15","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1017\/S0007114509993837","volume":"103","author":"JD Fern\u00e1ndez-Ballart","year":"2010","unstructured":"Fern\u00e1ndez-Ballart JD, Pi\u00f1ol JL, Zazpe I, Corella D, Carrasco P, Toledo E, Perez-Bauer M, Mart\u00ednez-Gonz\u00e1lez M\u00c1, Salas-Salvad\u00f3 J, Martn-Moreno JM (2010) Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr 103:1808\u20131816. https:\/\/doi.org\/10.1017\/S0007114509993837","journal-title":"Br J Nutr"},{"key":"998_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/J.ARCMED.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN (2019) Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res 50:285\u2013294. https:\/\/doi.org\/10.1016\/J.ARCMED.2019.08.009","journal-title":"Arch Med Res"},{"key":"998_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"W Friedewald","year":"1972","unstructured":"Friedewald W, Levy R, Fredrickson D (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"998_CR18","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00394-020-02370-6","volume":"60","author":"C Galarregui","year":"2021","unstructured":"Galarregui C, Cantero I, Marin-Alejandre BA, Monreal JI, Elorz M, Benito-Boillos A, Herrero JI, de la OV R-CM, HHM H, Bressan J, Tur JA, Mart\u00ednez JA, Zulet MA, Abete I (2021) Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: Fatty Liver in Obesity (FLiO) study. Eur J Nutr 60:1769\u20131780. https:\/\/doi.org\/10.1007\/s00394-020-02370-6","journal-title":"Eur J Nutr"},{"key":"998_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0210726","volume":"14","author":"AM Galmes-Panades","year":"2019","unstructured":"Galmes-Panades AM, Konieczna J, Abete I, Colom A, Rosique-Esteban N, Zulet MA, V\u00e1zquez Z, Estruch R, Vidal J, Toledo E, Babio N, Fiol M, Casas R, Vera J, Buil-Cosiales P, De Paz JA, Goday A, Salas-Salvad\u00f3 J, Alfredo Mart\u00ednez J, Romaguera D (2019) Lifestyle factors and visceral adipose tissue: results from the PREDIMED-PLUS study. PLoS One 14:1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0210726","journal-title":"PLoS One"},{"key":"998_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/CIRCULATIONAHA.121.055600","volume":"145","author":"P Gao","year":"2022","unstructured":"Gao P, You M, Li L, Zhang Q, Fang X, Wei X, Zhou Q, Zhang H, Wang M, Lu Z, Wang L, Sun F, Liu D, Zheng H, Yan Z, Yang G, Zhu Z (2022) Salt-induced hepatic inflammatory memory contributes to cardiovascular damage through epigenetic modulation of SIRT3. Circulation 145:375\u2013391. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055600","journal-title":"Circulation"},{"key":"998_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/J.CELREP.2018.12.036","volume":"26","author":"D Garcia","year":"2019","unstructured":"Garcia D, Hellberg K, Chaix A, Wallace M, Herzig S, Badur MG, Lin T, Shokhirev MN, Pinto AFM, Ross DS, Saghatelian A, Panda S, Dow LE, Metallo CM, Shaw RJ (2019) Genetic liver-specific AMPK activation protects against diet-induced obesity and NAFLD. Cell Rep 26:192\u2013208.e6. https:\/\/doi.org\/10.1016\/J.CELREP.2018.12.036","journal-title":"Cell Rep"},{"key":"998_CR22","doi-asserted-by":"publisher","first-page":"E1082","DOI":"10.1161\/CIR.0000000000000625","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK et al (2019) 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139:E1082\u2013E1143. https:\/\/doi.org\/10.1161\/CIR.0000000000000625","journal-title":"Circulation"},{"key":"998_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-19425-7","volume-title":"Regression Modeling Strategies","author":"F Harrell","year":"2015","unstructured":"Harrell F (2015) Applications to linear models, logistic and ordinal regression, and survival analysis. In: Regression Modeling Strategies. Springer, New York, NY, USA"},{"key":"998_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/J.BCP.2015.08.098","volume":"98","author":"HJ Hwang","year":"2015","unstructured":"Hwang HJ, Jung TW, Kim BH, Hong HC, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH, Yoo HJ (2015) A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. Biochem Pharmacol 98:157\u2013166. https:\/\/doi.org\/10.1016\/J.BCP.2015.08.098","journal-title":"Biochem Pharmacol"},{"key":"998_CR25","doi-asserted-by":"publisher","unstructured":"Ishibashi R, Furusawa Y, Honda H, Watanabe Y, Fujisaka S et al (2022) Isoliquiritigenin attenuates adipose tissue inflammation and metabolic syndrome by modifying gut bacteria composition in mice. Mol Nutr Food Res 66. https:\/\/doi.org\/10.1002\/MNFR.202101119","DOI":"10.1002\/MNFR.202101119"},{"key":"998_CR26","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3390\/nu11112704","volume":"11","author":"AG Izquierdo","year":"2019","unstructured":"Izquierdo AG, Crujeiras AB, Casanueva FF, Carreira MC (2019) Leptin, obesity, and leptin resistance: where are we 25 years later? Nutrients 11:2704. https:\/\/doi.org\/10.3390\/nu11112704","journal-title":"Nutrients"},{"key":"998_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/MAS.21548","volume":"38","author":"M Jacob","year":"2019","unstructured":"Jacob M, Lopata AL, Dasouki M, Abdel Rahman AM (2019) Metabolomics toward personalized medicine. Mass Spectrom Rev 38:221\u2013238. https:\/\/doi.org\/10.1002\/MAS.21548","journal-title":"Mass Spectrom Rev"},{"key":"998_CR28","doi-asserted-by":"publisher","unstructured":"Jin Q, Ma RCW (2021) Metabolomics in diabetes and diabetic complications: insights from epidemiological studies. Cells 10. https:\/\/doi.org\/10.3390\/CELLS10112832","DOI":"10.3390\/CELLS10112832"},{"key":"998_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/NRM.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G (2016) Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol 17:451\u2013459. https:\/\/doi.org\/10.1038\/NRM.2016.25","journal-title":"Nat Rev Mol Cell Biol"},{"key":"998_CR30","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1001\/jama.2019.10696","volume":"322","author":"Y-Y Juo","year":"2019","unstructured":"Juo Y-Y, Livingston EH (2019) Testing for nonalcoholic fatty liver disease. JAMA 322:1836. https:\/\/doi.org\/10.1001\/jama.2019.10696","journal-title":"JAMA"},{"key":"998_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13813455.2019.1673429","volume":"128","author":"V Karamfilova","year":"2022","unstructured":"Karamfilova V, Gateva A, Alexiev A, Zheleva N, Velikova T, Ivanova-Boyanova R, Ivanova R, Cherkezov N, Kamenov Z, Mateva L (2022) The association between retinol-binding protein 4 and prediabetes in obese patients with nonalcoholic fatty liver disease. Arch Physiol Biochem 128:217\u2013222. https:\/\/doi.org\/10.1080\/13813455.2019.1673429","journal-title":"Arch Physiol Biochem"},{"key":"998_CR32","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/oby.23445","volume":"30","author":"J Kim","year":"2022","unstructured":"Kim J, Ki Lee S, Kim D, Lee E, Yoon Park C, Choe H, Kang M-J, Jung Kim H, Kim J-H, Pio Hong J, Ji Lee Y, Soon Park H, Heo Y, Jin Jang Y, Yeon Jin Jang C (2022) Adipose tissue LECT2 expression is associated with obesity and insulin resistance in Korean women. Obesity (Silver Spring) 30:1430\u20131441. https:\/\/doi.org\/10.1002\/oby.23445","journal-title":"Obesity (Silver Spring)"},{"key":"998_CR33","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/J.MOLMED.2020.07.005","volume":"26","author":"A Kontush","year":"2020","unstructured":"Kontush A (2020) HDL and reverse remnant-cholesterol transport (RRT): relevance to cardiovascular disease. Trends Mol Med 26:1086\u20131100. https:\/\/doi.org\/10.1016\/J.MOLMED.2020.07.005","journal-title":"Trends Mol Med"},{"key":"998_CR34","doi-asserted-by":"publisher","unstructured":"Kumar S, Duan Q, Wu R, Harris EN, Su Q (2021) Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev 176. https:\/\/doi.org\/10.1016\/J.ADDR.2021.113869","DOI":"10.1016\/J.ADDR.2021.113869"},{"key":"998_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL et al (2022) Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol 19:60\u201378. https:\/\/doi.org\/10.1038\/s41575-021-00523-4","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"998_CR36","doi-asserted-by":"publisher","unstructured":"Lee J, Vali Y, Boursier J, Duffin K, Verheij J, Julia Brosnan M, Zwinderman K, Anstee QM, Bossuyt PM, Zafarmand MH (2020) Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: a systematic review and meta-analysis. PLoS One 15. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0238717","DOI":"10.1371\/JOURNAL.PONE.0238717"},{"key":"998_CR37","doi-asserted-by":"publisher","unstructured":"Lee Y, Kwon EY, Choi MS (2018) Dietary isoliquiritigenin at a low dose ameliorates insulin resistance and NAFLD in diet-induced obesity in C57BL\/6J mice. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/IJMS19103281","DOI":"10.3390\/IJMS19103281"},{"key":"998_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/J.PHRS.2019.04.025","volume":"144","author":"X Li","year":"2019","unstructured":"Li X, Sun R, Liu R (2019) Natural products in licorice for the therapy of liver diseases: progress and future opportunities. Pharmacol Res 144:210\u2013226. https:\/\/doi.org\/10.1016\/J.PHRS.2019.04.025","journal-title":"Pharmacol Res"},{"key":"998_CR39","doi-asserted-by":"publisher","first-page":"741754","DOI":"10.3389\/FNEUR.2021.741754\/FULL","volume":"12","author":"H Liu","year":"2021","unstructured":"Liu H, Liu K, Pei L, Li S, Zhao J, Zhang K, Zong C, Zhao L, Fang H, Wu J, Sun S, Song B, Xu Y, Gao Y (2021) Atherogenic index of plasma predicts outcomes in acute ischemic stroke. Front Neurol 12:741754. https:\/\/doi.org\/10.3389\/FNEUR.2021.741754\/FULL","journal-title":"Front Neurol"},{"key":"998_CR40","doi-asserted-by":"publisher","unstructured":"Liu X, Zhu Q, Zhang M, Yin T, Xu R, Xiao W, Wu J, Deng B, Gao X, Gong W, Lu G, Ding Y (2018) Isoliquiritigenin ameliorates acute pancreatitis in mice via inhibition of oxidative stress and modulation of the Nrf2\/HO-1 pathway. https:\/\/doi.org\/10.1155\/2018\/7161592","DOI":"10.1155\/2018\/7161592"},{"key":"998_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/J.JACC.2020.10.048","volume":"77","author":"J Luo","year":"2021","unstructured":"Luo J, le Cessie S, van Heemst D, Noordam R (2021) Diet-derived circulating antioxidants and risk of coronary heart disease: a Mendelian randomization study. J Am Coll Cardiol 77:45\u201354. https:\/\/doi.org\/10.1016\/J.JACC.2020.10.048","journal-title":"J Am Coll Cardiol"},{"key":"998_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/EURHEARTJ\/EHZ455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M et al (2020) 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J 41:111\u2013188. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHZ455","journal-title":"Eur Heart J"},{"key":"998_CR43","doi-asserted-by":"publisher","unstructured":"Marin-Alejandre BA, Abete I, Cantero I, Riezu-Boj JI, Milagro FI, Monreal JI, Elorz M, Herrero JI, Benito-Boillos A, Quiroga J, Martinez-Echeverria A, Uriz-Otano JI, Huarte-Muniesa MP, Tur JA, Mart\u00ednez JA, Zulet MA (2019) Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: a comparison with healthy controls. Nutrients 11. https:\/\/doi.org\/10.3390\/NU11020322","DOI":"10.3390\/NU11020322"},{"key":"998_CR44","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/liv.14818","volume":"41","author":"BA Marin-Alejandre","year":"2021","unstructured":"Marin-Alejandre BA, Cantero I, Zulet MA (2021) Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: a randomized trial. Liver Int 41:1532\u20131544. https:\/\/doi.org\/10.1111\/liv.14818","journal-title":"Liver Int"},{"key":"998_CR45","doi-asserted-by":"publisher","unstructured":"Marques V, Afonso MB, Bierig N, Duarte-Ramos F, Santos-Laso \u00c1 et al (2021) Adiponectin, leptin, and IGF-1 are useful diagnostic and stratification biomarkers of NAFLD. Front Med (Lausanne) 8. https:\/\/doi.org\/10.3389\/FMED.2021.683250","DOI":"10.3389\/FMED.2021.683250"},{"key":"998_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/ije\/dyy225","volume":"48","author":"MA Mart\u00ednez-Gonz\u00e1lez","year":"2019","unstructured":"Mart\u00ednez-Gonz\u00e1lez MA, Buil-Cosiales P, Corella D, Bull\u00f3 M, Fit\u00f3 M et al (2019) Cohort profile: design and methods of the PREDIMED-plus randomized trial. Int J Epidemiol 48:387\u2013388o. https:\/\/doi.org\/10.1093\/ije\/dyy225","journal-title":"Int J Epidemiol"},{"key":"998_CR47","volume-title":"Bioestad\u00edstica Amigable (4a edici\u00f3n), 4a","author":"M\u00c1 Mart\u00ednez-Gonz\u00e1lez","year":"2019","unstructured":"Mart\u00ednez-Gonz\u00e1lez M\u00c1, S\u00e1nchez-Villegas A, Toledo E, Faul\u00edn-Fajardo J (2019) Bioestad\u00edstica Amigable (4a edici\u00f3n), 4a. Elsevier, Pamplona"},{"key":"998_CR48","doi-asserted-by":"publisher","unstructured":"Masarone M, Troisi J, Aglitti A, Torre P, Colucci A, Dallio M, Federico A, Balsano C, Persico M (2021) Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis. Metabolomics 17. https:\/\/doi.org\/10.1007\/S11306-020-01756-1","DOI":"10.1007\/S11306-020-01756-1"},{"key":"998_CR49","doi-asserted-by":"publisher","unstructured":"Mirabelli M, Chiefari E, Arcidiacono B, Corigliano DM, Brunetti FS, Maggisano V, Russo D, Foti DP, Brunetti A (2020) Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases. Nutrients 12. https:\/\/doi.org\/10.3390\/NU12041066","DOI":"10.3390\/NU12041066"},{"key":"998_CR50","doi-asserted-by":"publisher","unstructured":"Montemayor S, Mascar\u00f3 CM, Ugarriza L, Casares M, Llompart I, Abete I, Zulet M\u00c1, Mart\u00ednez JA, Tur JA, Bouzas C (2022) Adherence to Mediterranean diet and NAFLD in patients with metabolic syndrome: the FLIPAN study. Nutrients 14. https:\/\/doi.org\/10.3390\/NU14153186","DOI":"10.3390\/NU14153186"},{"key":"998_CR51","doi-asserted-by":"publisher","unstructured":"Muntis FR, Smith-Ryan AE, Crandell J, Evenson KR, Maahs DM, Seid M, Shaikh SR, Mayer-Davis EJ (2023) A high protein diet is associated with improved glycemic control following exercise among adolescents with type 1 diabetes. Nutrients 15. https:\/\/doi.org\/10.3390\/NU15081981","DOI":"10.3390\/NU15081981"},{"key":"998_CR52","doi-asserted-by":"publisher","unstructured":"Newton A, Majumder K (2023) Germination and simulated gastrointestinal digestion of chickpea ( Cicer arietinum L.) in exhibiting in vitro antioxidant activity in gastrointestinal epithelial cells. Antioxidants (Basel) 12. https:\/\/doi.org\/10.3390\/ANTIOX12051114","DOI":"10.3390\/ANTIOX12051114"},{"key":"998_CR53","doi-asserted-by":"publisher","unstructured":"Nishida A, Ando Y, Kimura I, Miyamoto J (2022) Involvement of gut microbial metabolites derived from diet on host energy homeostasis. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/IJMS23105562","DOI":"10.3390\/IJMS23105562"},{"key":"998_CR54","doi-asserted-by":"publisher","first-page":"684","DOI":"10.23736\/S0022-4707.21.12233-9","volume":"62","author":"M Norouzpour","year":"2022","unstructured":"Norouzpour M, Marandi SM, Ghanbarzadeh M, Zaremaivan A (2022) The effect of combined exercises on the plasma levels of retinol-binding protein 4 and its relationship with insulin resistance and hepatic fat content in postmenopausal women with nonalcoholic fatty liver disease. J Sports Med Phys Fitness 62:684\u2013690. https:\/\/doi.org\/10.23736\/S0022-4707.21.12233-9","journal-title":"J Sports Med Phys Fitness"},{"key":"998_CR55","doi-asserted-by":"publisher","unstructured":"Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, Gojobori T, Isenovic ER (2021) Leptin and obesity: role and clinical implication. Front Endocrinol (Lausanne):12. https:\/\/doi.org\/10.3389\/FENDO.2021.585887","DOI":"10.3389\/FENDO.2021.585887"},{"key":"998_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/HEP4.1707","volume":"6","author":"JM Paik","year":"2022","unstructured":"Paik JM, Mir S, Alqahtani SA, Younossi Y, Ong JP, Younossi ZM (2022) Dietary risks for liver mortality in NAFLD: global burden of disease data. Hepatol Commun 6:90\u2013100. https:\/\/doi.org\/10.1002\/HEP4.1707","journal-title":"Hepatol Commun"},{"key":"998_CR57","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.3748\/WJG.V27.I29.4913","volume":"27","author":"ENGDS Pereira","year":"2021","unstructured":"Pereira ENGDS, Paula DP, De ABP, Da FMDJM, Diniz MDFHS, Daliry A, Griep RH (2021) Advanced glycation end product: a potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study. World J Gastroenterol 27:4913\u20134923. https:\/\/doi.org\/10.3748\/WJG.V27.I29.4913","journal-title":"World J Gastroenterol"},{"key":"998_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5507\/bp.2019.021","volume":"163","author":"S Placzkowska","year":"2019","unstructured":"Placzkowska S, Pawlik-Sobecka L, Kokot I, Piwowar A (2019) Indirect insulin resistance detection: current clinical trends and laboratory limitations. Biomed Papers 163:187\u2013199. https:\/\/doi.org\/10.5507\/bp.2019.021","journal-title":"Biomed Papers"},{"key":"998_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines9020184","volume":"9","author":"D Ramai","year":"2021","unstructured":"Ramai D, Tai W, Rivera M, Facciorusso A, Tartaglia N, Pacilli M, Ambrosi A, Cotsoglou C, Sacco R (2021) Natural progression of non-alcoholic steatohepatitis to hepatocellular carcinoma. Biomedicines 9:1\u201317. https:\/\/doi.org\/10.3390\/biomedicines9020184","journal-title":"Biomedicines"},{"key":"998_CR60","doi-asserted-by":"publisher","unstructured":"Ramalingam M, Kim H, Lee Y, Il LY (2018) Phytochemical and pharmacological role of liquiritigenin and isoliquiritigenin from radix glycyrrhizae in human health and disease models. Front Aging Neurosci 10. https:\/\/doi.org\/10.3389\/FNAGI.2018.00348","DOI":"10.3389\/FNAGI.2018.00348"},{"key":"998_CR61","doi-asserted-by":"publisher","unstructured":"Recaredo G, Marin-Alejandre BA, Cantero I, Monreal JI, Herrero JI, Benito-Boillos A, Elorz M, Tur JA, Mart\u00ednez JA, Zulet MA, Abete I (2019) Association between different animal protein sources and liver status in obese subjects with non-alcoholic fatty liver disease: Fatty Liver in Obesity (FLiO) Study. Nutrients 11. https:\/\/doi.org\/10.3390\/nu11102359","DOI":"10.3390\/nu11102359"},{"key":"998_CR62","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA (2022) The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 7:851\u2013861. https:\/\/doi.org\/10.1016\/S2468-1253(22)00165-0","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"998_CR63","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/S41580-019-0108-4","volume":"20","author":"MM Rinschen","year":"2019","unstructured":"Rinschen MM, Ivanisevic J, Giera M, Siuzdak G (2019) Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol 20:353\u2013367. https:\/\/doi.org\/10.1038\/S41580-019-0108-4","journal-title":"Nat Rev Mol Cell Biol"},{"key":"998_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BIOM10121702","volume":"10","author":"C Rives","year":"2020","unstructured":"Rives C, Fougerat A, Loiseau N, Guillou H, Gamet-Payrastre L, Wahli W (2020) Oxidative stress in NAFLD: role of nutrients and food contaminants. Biomolecules 10:1\u201369. https:\/\/doi.org\/10.3390\/BIOM10121702","journal-title":"Biomolecules"},{"key":"998_CR65","doi-asserted-by":"publisher","unstructured":"Rysz J, Gluba-Brz\u00f3zka A, Rysz-G\u00f3rzy\u0144ska M, Franczyk B (2020) The role and function of HDL in patients with chronic kidney disease and the risk of cardiovascular disease. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/IJMS21020601","DOI":"10.3390\/IJMS21020601"},{"key":"998_CR66","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/AJCN\/NQAC025","volume":"116","author":"S Schutte","year":"2022","unstructured":"Schutte S, Esser D, Siebelink E, Michielsen CJR, Daanje M et al (2022) Diverging metabolic effects of 2 energy-restricted diets differing in nutrient quality: a 12-week randomized controlled trial in subjects with abdominal obesity. Am J Clin Nutr 116:132\u2013150. https:\/\/doi.org\/10.1093\/AJCN\/NQAC025","journal-title":"Am J Clin Nutr"},{"key":"998_CR67","doi-asserted-by":"publisher","unstructured":"Sellem L, Eichelmann F, Jackson KG, Wittenbecher C, Schulze MB, Lovegrove JA (2023) Replacement of dietary saturated with unsaturated fatty acids is associated with beneficial effects on lipidome metabolites: a secondary analysis of a randomized trial. Am J Clin Nutr 117. https:\/\/doi.org\/10.1016\/J.AJCNUT.2023.03.024","DOI":"10.1016\/J.AJCNUT.2023.03.024"},{"key":"998_CR68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/S13105-021-00850-9","volume":"78","author":"AS Shatoor","year":"2022","unstructured":"Shatoor AS, al Humayed S, Almohiy HM (2022) Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2. J Physiol Biochem 78:151\u2013168. https:\/\/doi.org\/10.1007\/S13105-021-00850-9","journal-title":"J Physiol Biochem"},{"key":"998_CR69","doi-asserted-by":"publisher","unstructured":"Song Z, Zhang Y, Zhang H, Rajendran RS, Wang R, Hsiao C der, Li J, Xia Q, Liu K (2020) Isoliquiritigenin triggers developmental toxicity and oxidative stress\u2013mediated apoptosis in zebrafish embryos\/larvae via Nrf2-HO1\/JNK-ERK\/mitochondrion pathway. Chemosphere 246. doi: https:\/\/doi.org\/10.1016\/J.CHEMOSPHERE.2019.125727","DOI":"10.1016\/J.CHEMOSPHERE.2019.125727"},{"key":"998_CR70","doi-asserted-by":"publisher","unstructured":"Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM et al (2020) The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res 2020. https:\/\/doi.org\/10.1155\/2020\/3920196","DOI":"10.1155\/2020\/3920196"},{"key":"998_CR71","doi-asserted-by":"publisher","unstructured":"Tettamanzi F, Bagnardi V, Louca P, Nogal A, Monti GS, Mambrini SP, Lucchetti E, Maestrini S, Mazza S, Rodriguez-Mateos A, Scacchi M, Valdes AM, Invitti C, Menni C (2021) A high protein diet is more effective in improving insulin resistance and glycemic variability compared to a Mediterranean diet-a cross-over controlled inpatient dietary study. Nutrients 13. https:\/\/doi.org\/10.3390\/NU13124380","DOI":"10.3390\/NU13124380"},{"key":"998_CR72","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/PTR.7334","volume":"36","author":"L Wang","year":"2022","unstructured":"Wang L, Wang X, Kong L, Li Y, Huang K, Wu J, Wang C, Sun H, Sun P, Gu J, Luo H, Liu K, Meng Q (2022) Activation of PGC-1\u03b1 via isoliquiritigenin-induced downregulation of miR-138-5p alleviates nonalcoholic fatty liver disease. Phytother Res 36:899\u2013913. https:\/\/doi.org\/10.1002\/PTR.7334","journal-title":"Phytother Res"},{"key":"998_CR73","doi-asserted-by":"publisher","unstructured":"Wang Y, Nakajima T, Gonzalez FJ, Tanaka N (2020) PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/IJMS21062061","DOI":"10.3390\/IJMS21062061"},{"key":"998_CR74","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1152\/PHYSREV.00035.2018","volume":"99","author":"DS Wishart","year":"2019","unstructured":"Wishart DS (2019) Metabolomics for investigating physiological and pathophysiological processes. Physiol Rev 99:1819\u20131875. https:\/\/doi.org\/10.1152\/PHYSREV.00035.2018","journal-title":"Physiol Rev"},{"key":"998_CR75","doi-asserted-by":"publisher","unstructured":"Yahya MA, Alshammari GM, Osman MA, Al-Harbi LN, Yagoub AEGA, AlSedairy SA (2022) Liquorice root extract and isoliquiritigenin attenuate high-fat diet-induced hepatic steatosis and damage in rats by regulating AMPK. Arch Physiol Biochem. https:\/\/doi.org\/10.1080\/13813455.2022.2102654","DOI":"10.1080\/13813455.2022.2102654"},{"key":"998_CR76","doi-asserted-by":"publisher","unstructured":"Yang J, Fern\u00e1ndez-Galilea M, Mart\u00ednez-Fern\u00e1ndez J, Gonz\u00e1lez-Muniesa P, P\u00e9rez-Ch\u00e1vez A, Mart\u00ednez J, Moreno-Aliaga M (2019) Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation. Nutrients 11. https:\/\/doi.org\/10.3390\/NU11040872","DOI":"10.3390\/NU11040872"},{"key":"998_CR77","doi-asserted-by":"publisher","unstructured":"Yang L, Wang D, Zhang Z, Jiang Y, Liu Y (2022) Isoliquiritigenin alleviates diabetic symptoms via activating AMPK and inhibiting mTORC1 signaling in diet-induced diabetic mice. Phytomedicine 98. https:\/\/doi.org\/10.1016\/J.PHYMED.2022.153950","DOI":"10.1016\/J.PHYMED.2022.153950"},{"key":"998_CR78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15:11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"998_CR79","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M (2019) Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 69:2672\u20132682. https:\/\/doi.org\/10.1002\/hep.30251","journal-title":"Hepatology"},{"key":"998_CR80","doi-asserted-by":"publisher","unstructured":"Yuan S, Chen J, Li X, Fan R, Arsenault B, Gill D, Giovannucci EL, Zheng J sheng, Larsson SC (2022) Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study. Eur J Epidemiol 37:723\u2013733. doi: https:\/\/doi.org\/10.1007\/S10654-022-00868-3","DOI":"10.1007\/S10654-022-00868-3"},{"key":"998_CR81","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1002\/PTR.7101","volume":"35","author":"L Zhang","year":"2021","unstructured":"Zhang L, Yang SY, Qi-Li FR, Liu XX, Zhang WT, Peng C, Wu P, Li P, Li P, Xu X (2021) Administration of isoliquiritigenin prevents nonalcoholic fatty liver disease through a novel IQGAP2-CREB-SIRT1 axis. Phytother Res 35:3898\u20133915. https:\/\/doi.org\/10.1002\/PTR.7101","journal-title":"Phytother Res"},{"key":"998_CR82","doi-asserted-by":"publisher","unstructured":"Zhang Z, Yung KKL, Ko JKS (2022) Therapeutic intervention in cancer by isoliquiritigenin from licorice: a natural antioxidant and redox regulator. Antioxidants (Basel) 11. https:\/\/doi.org\/10.3390\/ANTIOX11071349","DOI":"10.3390\/ANTIOX11071349"},{"key":"998_CR83","unstructured":"(2022) PubChem Compound Summary for CID 638278, Isoliquiritigenin. In: National Center for Biotechnology Information. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Isoliquiritigenin. Accessed 7 Oct 2022"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-023-00998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-023-00998-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-023-00998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T07:44:31Z","timestamp":1729755871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-023-00998-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["998"],"URL":"https:\/\/doi.org\/10.1007\/s13105-023-00998-6","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"type":"print","value":"1138-7548"},{"type":"electronic","value":"1877-8755"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was performed under the principles of the Declaration of Helsinki, and it was approved by the Ethics Committee of the University of Navarra (ref. 54\/2015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all the participants involved in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}